| Authors: |
Mamalakis M; School of Electrical and Electronic Engineering, University of Sheffield, Sheffield, UK; Insigneo Institute for in-silico, Medicine, University of Sheffield, Sheffield, UK; Department of Infection, Immunity and Cardiovascular Disease, and Department of Computer science, Sheffield, UK; Department of Psychiatry, Cambridge University, Cambridge, UK. Electronic address: co4mma@sheffield.ac.uk., Macfarlane SC; Department of Oncology and Metabolism, The Medical School, University of Sheffield, Sheffield, UK., Notley SV; Insigneo Institute for in-silico, Medicine, University of Sheffield, Sheffield, UK; Department of Automatic Control and Systems Engineering, University of Sheffield, Sheffield, UK., Gad AKB; Insigneo Institute for in-silico, Medicine, University of Sheffield, Sheffield, UK; Department of Oncology and Metabolism, The Medical School, University of Sheffield, Sheffield, UK; Madeira Chemistry Research Centre, University of Madeira, Funchal, Portugal; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Panoutsos G; School of Electrical and Electronic Engineering, University of Sheffield, Sheffield, UK; Insigneo Institute for in-silico, Medicine, University of Sheffield, Sheffield, UK; Department of Oncology and Metabolism, The Medical School, University of Sheffield, Sheffield, UK. Electronic address: g.panoutsos@sheffield.ac.uk. |
